Intermittent low-oxygen therapy for primary insomnia
Part of Brain & nervous system, Mental health clinical trials.
This trial tests whether brief sessions of breathing lower-oxygen air can improve sleep in people with primary insomnia. It may offer a drug-free approach to better sleep.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 60 years old and have been diagnosed with primary insomnia.
- You are not currently taking sleeping pills, or you stopped taking them more than 2 weeks ago.
- You live at low altitude (plains) and have not been above 1,500 meters in the past month.
- Your oxygen levels, heart rate, blood pressure, and breathing are within normal ranges at rest.
- You agree to avoid energy drinks, caffeine, and any sleep-affecting medications during the study.
- You do not have severe sleep apnea, recent stroke, uncontrolled high blood pressure, or other serious health conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-stage study tests a treatment that briefly reduces oxygen during sleep to improve “plasticity,” with the goal of helping people with obstructive or mixed sleep apnea. It also looks at related conditions like high blood pressure and pre-diabetes or cholesterol problems, especially in people who haven’t tried CPAP yet.
This study tests whether breathing lower-oxygen air in short breaks changes how the brain and body respond. It is only for medically stable, healthy adults with specific safety screening.
This study tests whether brief periods of breathing air with lower oxygen levels can help people with different stages of multiple sclerosis (MS). It aims to see if this approach is safe and maybe beneficial.
This study tests how short periods of low oxygen (like at high altitude) affect your body's breathing control. It is for healthy people and may help researchers better understand breathing during sleep.
This trial tests a treatment called intermittent hypoxia-hyperoxia therapy (breathing air with lower then higher oxygen levels) to see if it can improve fatigue, pain, and quality of life in people with ME/CFS. The study focuses on women with mild or moderate ME/CFS.
This trial tests a special breathing technique called intermittent hypoxia-hyperoxia, which alternates between low and normal oxygen, to see how it affects older adults. It may help improve physical function and well-being in people who are not very active.
Hear when a new Insomnia, Primary trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.